157 related articles for article (PubMed ID: 20062974)
1. Factors influencing long-term pessary use.
Friedman S; Sandhu KS; Wang C; Mikhail MS; Banks E
Int Urogynecol J; 2010 Jun; 21(6):673-8. PubMed ID: 20062974
[TBL] [Abstract][Full Text] [Related]
2. Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study.
Ramsay S; Tu le M; Tannenbaum C
Int Urogynecol J; 2016 Aug; 27(8):1201-7. PubMed ID: 26872647
[TBL] [Abstract][Full Text] [Related]
3. Adherence to support pessary in the treatment of pelvic organ prolapse: a retrospective study conducted among 1,371 women.
Brandt CH; Yamolaei M; Wu C; Hansen UD; Rasch V
Int Urogynecol J; 2024 Jan; 35(1):69-75. PubMed ID: 37548745
[TBL] [Abstract][Full Text] [Related]
4. Long-term adherence to pessary use in women with pelvic organ prolapse: A retrospective cohort study.
Koch M; Carlin G; Lange S; Umek W; Krall C; Bodner-Adler B
Maturitas; 2023 Dec; 178():107828. PubMed ID: 37659128
[TBL] [Abstract][Full Text] [Related]
5. Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use.
Manonai J; Sarit-Apirak S; Udomsubpayakul U
Menopause; 2018 Dec; 26(6):665-669. PubMed ID: 30562318
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with long-term pessary use in women with symptomatic pelvic organ prolapse.
Mao M; Xu T; Kang J; Zhang Y; Ai F; Zhou Y; Zhu L
Climacteric; 2019 Oct; 22(5):478-482. PubMed ID: 30897024
[No Abstract] [Full Text] [Related]
7. What Are the Clinical Factors That Are Predictive of Persistent Pessary Use at 12 Months?
Chan MC; Hyakutake M; Yaskina M; Schulz JA
J Obstet Gynaecol Can; 2019 Sep; 41(9):1276-1281. PubMed ID: 30712905
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
Yimphong T; Temtanakitpaisan T; Buppasiri P; Chongsomchai C; Kanchaiyaphum S
Int Urogynecol J; 2018 Aug; 29(8):1123-1128. PubMed ID: 28815277
[TBL] [Abstract][Full Text] [Related]
9. Defecatory dysfunction and other clinical variables are predictors of pessary discontinuation.
Dengler EG; Mounsey LA; Gines F; Agha M; Long T; Geller EJ
Int Urogynecol J; 2019 Jul; 30(7):1111-1116. PubMed ID: 30343377
[TBL] [Abstract][Full Text] [Related]
10. Vaginal pessary continuation in symptomatic pelvic organ prolapse patients with prior hysterectomy.
Ma C; Kang J; Xu T; Zhang Y; Ma Y; Liang S; Hui Y; Wang Y; Zhu L
Menopause; 2020 Oct; 27(10):1148-1154. PubMed ID: 32881830
[TBL] [Abstract][Full Text] [Related]
11. Ring and Gellhorn pessaries used in patients with pelvic organ prolapse: a retrospective study of 8 years.
Yang J; Han J; Zhu F; Wang Y
Arch Gynecol Obstet; 2018 Sep; 298(3):623-629. PubMed ID: 29978415
[TBL] [Abstract][Full Text] [Related]
12. Long-term Outcomes of Self-Management Gellhorn Pessary for Symptomatic Pelvic Organ Prolapse.
Chien CW; Lo TS; Tseng LH; Lin YH; Hsieh WC; Lee SJ
Female Pelvic Med Reconstr Surg; 2020 Nov; 26(11):e47-e53. PubMed ID: 31393340
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported goal attainment and comprehensive functioning outcomes after surgery compared with pessary for pelvic organ prolapse.
Sung VW; Wohlrab KJ; Madsen A; Raker C
Am J Obstet Gynecol; 2016 Nov; 215(5):659.e1-659.e7. PubMed ID: 27319365
[TBL] [Abstract][Full Text] [Related]
14. Predictors for unsuccessful pessary fitting in women with symptomatic pelvic organ prolapse: a prospective study.
Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
BJOG; 2018 Oct; 125(11):1434-1440. PubMed ID: 29700950
[TBL] [Abstract][Full Text] [Related]
15. Use of a pessary in treatment of pelvic organ prolapse: quality of life, compliance, and failure at 1-year follow-up.
Ko PC; Lo TS; Tseng LH; Lin YH; Liang CC; Lee SJ
J Minim Invasive Gynecol; 2011; 18(1):68-74. PubMed ID: 21195956
[TBL] [Abstract][Full Text] [Related]
16. Clinical use of ring with support pessary for advanced pelvic organ prolapse and predictors of its short-term successful use.
Deng M; Ding J; Ai F; Zhu L
Menopause; 2017 Aug; 24(8):954-958. PubMed ID: 28419067
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a continuous-use ring-shaped vaginal pessary without support for advanced pelvic organ prolapse in postmenopausal women.
Dueñas JL; Miceli A
Int Urogynecol J; 2018 Nov; 29(11):1629-1636. PubMed ID: 29478114
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study on silicone pessary in the treatment of pelvic organ prolapse].
Yang JF; Han JS; Zhu FL; Wang YT; Yao Y; Qiao J
Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):487-91. PubMed ID: 23141156
[TBL] [Abstract][Full Text] [Related]
19. Successful use of the Gellhorn pessary as a second-line pessary in women with advanced pelvic organ prolapse.
Deng M; Ding J; Ai F; Zhu L
Menopause; 2017 Nov; 24(11):1277-1281. PubMed ID: 28640155
[TBL] [Abstract][Full Text] [Related]
20. Patient characteristics that are associated with continued pessary use versus surgery after 1 year.
Clemons JL; Aguilar VC; Sokol ER; Jackson ND; Myers DL
Am J Obstet Gynecol; 2004 Jul; 191(1):159-64. PubMed ID: 15295358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
